Skip to content

Venous Occlusion and Limb Swelling

Venous Occlusion and Limb Swelling

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02241343
Enrollment
1
Registered
2014-09-16
Start date
2014-05-31
Completion date
2014-06-30
Last updated
2020-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Venous Occlusion

Keywords

Venous occlusion

Brief summary

Problems affecting the veins in the legs can cause discomfort and swelling. We want to see how artificially and reversibly blocking the leg veins affects swelling in the lower limb.

Interventions

DEVICEVenous occlusion (leg tourniquet, made in-house)

Leg occlusion applied via a blood pressure cuff. Venous occlusion checked using duplex ultrasound

Sponsors

Imperial College London
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
BASIC_SCIENCE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Over 18 years old, able to consent

Exclusion criteria

* History of cardiovascular/renal disease

Design outcomes

Primary

MeasureTime frameDescription
Leg Swelling30 minutesPerometer measured leg volume from footplate to middle of knee joint (in standing position; ml)

Secondary

MeasureTime frameDescription
Venous Diameter30 minutesGreat saphenous vein diameter at the knee, taken with duplex ultrasound (cm)

Countries

United Kingdom

Participant flow

Participants by arm

ArmCount
Trial Cohort
All participants
1
Total1

Withdrawals & dropouts

PeriodReasonFG000
Overall StudyAdverse Event1

Baseline characteristics

CharacteristicTrial Cohort
Age, Categorical
<=18 years
0 Participants
Age, Categorical
>=65 years
0 Participants
Age, Categorical
Between 18 and 65 years
1 Participants
Race and Ethnicity Not Collected— Participants
Region of Enrollment
United Kingdom
1 participants
Sex/Gender, Customized
Male
1 participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
0 / 1
other
Total, other adverse events
1 / 1
serious
Total, serious adverse events
0 / 1

Outcome results

Primary

Leg Swelling

Perometer measured leg volume from footplate to middle of knee joint (in standing position; ml)

Time frame: 30 minutes

Population: Adverse event precluded data collection

Secondary

Venous Diameter

Great saphenous vein diameter at the knee, taken with duplex ultrasound (cm)

Time frame: 30 minutes

Population: Zero analysed due to adverse event during protocol

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026